American HealthCare Capital is pleased to offer a new diagnostic clinical laboratory for sale in Texas. They are Medicare certified, COLA accredited, and CLIA certified in Texas, Arizona, Oklahoma and Kentucky, and they have insurance contracts in various states. They provide a variety of testing services, including PCR Infectious Disease, Prescription Drug Monitoring, Urine Toxicology, PGX/CGX and Women’s Health. The lab has a favorable lease with renewable option, conveniently located within 30 minutes of two major airports.
The company’s payer mix is approximately 60% Medicare, 25% Medicare Replacement Plans and 15% Private Insurance. In 2019, the company generated approximately $500,000 in gross revenue. They are currently averaging around $50,000 in gross revenue per month, putting them on track to gross at least $600,000 by the end of 2020. Lab is operating with gross operating margin between 60 to 70 percent on molecular testing. They average 125-150 lab tests per month. The lab is fully staffed for a new owner to immediately capitalize on their growth potential.
The asking price for this opportunity is $495,000
